Scientific Opinion on the substantiation of health claims related to creatine and increase in physical performance during short‐term, high intensity, repeated exercise bouts (ID 739, 1520, 1521, 1522, 1523, 1525, 1526, 1531, 1532, 1533, 1534, 1922, 1923, 1924), increase in endurance capacity (ID 1527, 1535), and increase in endurance performance (ID 1521, 1963) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Products, Efsa Panel on Dietetic

doi:10.2903/j.efsa.2011.2303

Cited by 10 publications

(6 citation statements)

References 20 publications

(61 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A claim on creatine and increase in physical performance during short-term, high intensity, repeated exercise bouts has been evaluated by the Panel with a positive outcome (EFSA NDA Panel, 2011k). The scientific substantiation of the claim was based on a wealth of human intervention studies which investigated the effects of different creatine doses, patterns of consumption and duration of the supplementation on physical performance during continuous and intermittent physical activities of variable intensity and duration in various population subgroups (men and women of different ages and levels of training); on the results of two meta-analysis summarising the results of the above-mentioned human studies; and on the well-established mechanism by which creatine could exert the claimed effect.…”

Section: Claims On Physical Performancementioning

confidence: 99%

Guidance on the scientific requirements for health claims related to muscle function and physical performance

Nutrition¹,

Turck²,

Castenmiller³

et al. 2018

EFS2

View full text Add to dashboard Cite

EFSA has asked the Panel on Nutrition, Novel Foods and Food Allergens (NDA) to update the guidance on the scientific requirements for health claims related to physical performance published in 2012. The update takes into account the experience gained by the NDA Panel with the evaluation of additional health claim applications, changes introduced to the general scientific guidance for stakeholders for health claims applications and information collected from a grant launched in 2014 which aimed at gathering information in relation to claimed effects, outcome variables and methods of measurement in the context of the scientific substantiation of health claims. The guidance is intended to assist applicants in preparing applications for the authorisation of health claims related to muscle function and physical performance. The draft guidance was subject to public consultation from 16 July to 2 September 2018. This document supersedes the guidance on the scientific requirements for health claims related to physical performance published in 2012. It is intended that the guidance will be further updated as appropriate in the light of experience gained from the evaluation of health claims.

show abstract

Section: Claims On Physical Performancementioning

confidence: 99%

Guidance on the scientific requirements for health claims related to muscle function and physical performance

Nutrition¹,

Turck²,

Castenmiller³

et al. 2018

EFS2

View full text Add to dashboard Cite

show abstract

“…The Panel has previously evaluated a claim on creatine and increase in physical performance during short-term, high intensity, repeated exercise bouts with a favourable opinion (EFSA NDA Panel, 2011). The Panel indicated that ingestion of creatine, which is readily absorbed, at the doses proposed by the applicant (i.e.…”

Section: Meta-analyses Of Intervention Studiesmentioning

confidence: 99%

“…It should be noted that such an assessment is not foreseen in the framework of Regulation (EC) No 1924No /2006 It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006.…”

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

“…EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with Article 16(3) of Regulation (EC) No 1924No /2006. On the basis of that evaluation, EFSA will issue an opinion on the scientific substantiation of a health claim related to: creatine in combination with resistance training and improvement in muscle strength.…”

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

“…

AbstractFollowing an application from AlzChem AG, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924No /2006 via the Competent Authority of Austria, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to creatine in combination with resistance training and improvement in muscle strength. The Panel considers that the food constituent, creatine, which is the subject of the health claim, is sufficiently characterised.

…”

mentioning

confidence: 99%

See 2 more Smart Citations

Untitled

2016

EFSA Journal

View full text Add to dashboard Cite

Following an application from AlzChem AG, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924No /2006 via the Competent Authority of Austria, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to creatine in combination with resistance training and improvement in muscle strength. The Panel considers that the food constituent, creatine, which is the subject of the health claim, is sufficiently characterised. The Panel considers that improvement in muscle strength is a beneficial physiological effect. A total of 21 human intervention studies and two meta-analyses were provided by the applicant as being pertinent to the claim. The Panel considers that no conclusions can be drawn from 11 studies and the meta-analyses cannot be used for the scientific substantiation of the claim. In weighing the evidence the Panel took into account that, overall, the human intervention studies submitted provide evidence for an effect of creatine, consumed at doses of at least 3 g/day in combination with regular resistance training (three times per week for several weeks) of moderate intensity, on muscle strength in adults over the age of 55, while no such effect was observed when similar doses of creatine on a weekly basis were given on training days only (three times per week). The Panel also took into account the plausible mechanism by which daily consumption of creatine in combination with resistance training could improve muscle strength. On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the consumption of creatine in combination with resistance training and improvement in muscle strength in adults over the age of 55.

show abstract